Sanuwave Health, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
SANUWAVE Health, Inc. has announced its annual stockholder meeting for June 11, 2026, to vote on director elections, auditor ratification, and executive compensation.
NASDAQ
SANUWAVE Health, Inc. has filed its Definitive Proxy Statement (DEFA14A) with the U.S. Securities and Exchange Commission.
NASDAQ
SANUWAVE Health, Inc. is seeking shareholder approval for director elections, auditor ratification, and a significant increase in its equity incentive plan, while grappling with persistent financial losses, material weaknesses in internal controls, and a history of delinquent insider trading reports.
NASDAQ
DEF 14A: SANUWAVE Health Seeks Stockholder Approval for Reverse Stock Split and New Equity Incentive Plan
SANUWAVE Health is soliciting stockholder consent to approve a reverse stock split and a new equity incentive plan to address potential default under convertible notes and pursue Nasdaq uplisting.